… Hence, our MTB reflects a real-world experience with molecular profiling and patient … the
outcome of 715 patients with advanced cancer presented at our MTB, and demonstrate that …

… showed low positivity (5%, Ventana SP142). The case was discussed at the Molecular Tumor
Board … CT 2.5 months after therapy was initiated showed partial response (left to right, best …

… real-world experiences of MTBs suggest that patients treated with the MTB-recommended
regimen according to their tumor molecular alterations showed better outcome in … of precision …

… improves patient outcomes, as has been demonstrated in previous biomarker-driven studies.
Data … Here, we have presented the development, real-world implementation and testing of …

… of molecular data presents a current challenge for precision … The left panel indicates genes
that were identified at least … The retrospective, real-world design of this study reduced the …

… , most patients experienced improved PFS compared with … to improve outcomes for
patients with advanced cancer. … study demonstrates that patients with advanced cancer with …

… molecular tumor boards are highlighted and demonstrate a … To support the wider integration
of precision medicine in cancer, … data visualization methods to improve usability of molecular …

… , acting in the context of structured precision oncology trials. … Figure 5f shows that tumor/patient-specific
factors may be … to NGS reports, we strived to improve on this. From August 2022 (…

… resources that support timely and accurate interpretation of next-… Figure 2 shows the
breakdown of VICC MTB cases by … conditions that increase the likelihood of developing cancer, …

… Each row shows the single nucleotide variant per patient and … of outcomes from this
heterogeneous real-world cohort. … that outcome from PO programs will gradually improve with …